PMID: 11321191Apr 26, 2001Paper

A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative

Multiple Sclerosis : Clinical and Laboratory Research

Abstract

We combined the raw genotyping data from three large multiple sclerosis genome screens and performed a global meta-analysis in order to compare and summarize the linkage results from the different studies. In alphabetical order, the screens provided data from 442 markers typed in 52 multiplex families with a total of 133 affected individuals (the American screen), 314 markers typed in 128 families with 264 affecteds (the British screen) and 257 markers typed in 61 families with a total of 139 affected subjects (the Canadian screen). Multipoint analysis of these data was performed using the GENEHUNTER program. The highest non-parametric linkage (NPL) score in the meta-analysis was observed on chromosome 17q11 (NPL score 2.58), although this score falls short of genome-wide significance. A total of eight regions had NPL scores greater than 2.0. One of the regions with an NPL score greater than 2.0 was the HLA region on chromosome 6p21 (NPL=2.2). This region is known, from association studies, to be involved in MS susceptibility, but the modest linkage result observed here suggests the encoded susceptibility effect is not large compared with the high familial recurrence in MS (lambda approximately 20). Overall, our linkage results...Continue Reading

References

Dec 25, 1986·The New England Journal of Medicine·G C EbersT Grey
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
May 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·R E FernerM R Johnson
Aug 1, 1996·Nature Genetics·G C EbersN Risch
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·A CollinsN E Morton
Jun 1, 1997·Trends in Genetics : TIG·S SawcerA Compston
Sep 19, 1997·Mayo Clinic Proceedings·W E HogancampB G Weinshenker
Jan 1, 1997·Human Molecular Genetics·D A DymentA D Sadnovich
Dec 18, 1997·American Journal of Human Genetics·S KuokkanenL Peltonen
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·K G BeckerJ M Trent
Mar 30, 2000·Annals of Human Genetics·L H WiseC M Lewis

❮ Previous
Next ❯

Citations

Jun 27, 2002·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Mara GiordanoPatricia Momigliano-Richiardi
Jun 3, 2004·Annals of Neurology·Lisa F BarcellosJorge R Oksenberg
Jul 9, 2004·Scandinavian Journal of Immunology·K BecanovicT Olsson
Apr 28, 2007·Multiple Sclerosis : Clinical and Laboratory Research·A SidotiA Amato
Jun 6, 2007·Multiple Sclerosis : Clinical and Laboratory Research·P DattaA Oturai
May 11, 2005·Pharmacogenomics·Sergio E Baranzini, Jorge R Oksenberg
Jan 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·T Vyshkina, B Kalman
Jan 30, 2010·Human Genetics·Rebecca L ZuvichJonathan L Haines
Apr 9, 2002·Current Neurology and Neuroscience Reports·Alastair Compston, Stephen Sawcer
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maja JagodicTomas Olsson
Mar 23, 2007·European Journal of Human Genetics : EJHG·Jane HermanowskiCathryn M Lewis
Sep 12, 2009·Annals of the New York Academy of Sciences·Cynthia Husted, Lobsang Dhondup
Nov 15, 2007·Journal of Human Genetics·Cristen J WillerGeorge C Ebers
Oct 23, 2003·European Journal of Human Genetics : EJHG·Marie-Claude BabronUNKNOWN European Genetics Cluster on Coeliac Disease

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.